Sarah Arron
MOHS-Micrographic Surgery · Burlingame, CANPI 1255463725
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $69,237 of the $97,601 with a category attached, or 70.9%. Regeneron Healthcare Solutions, Inc. accounts for 86.4% of it on its own, with 18 other manufacturers making up the rest. Among mohs-micrographic surgery clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 135 payments — averaging $722.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron Healthcare Solutions, Inc.$84K
- Regeneron$12K
- AbbVie$384
- Pfizer$236
- Incyte Corporation$161
- LEO Pharma Inc.$118
- plus $532 from 13 others
Across 24 payments — averaging $5716.94 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$126K
- Regeneron$11K
What the payments were for
- Consulting fees$16,70617%
- Speaking & faculty fees$69,23771%
- Travel & lodging$8,2768%
- Food & beverage$3,3523%
- Education$310%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 69 | $84,353 |
| Regeneron | 7 | $11,817 |
| AbbVie(2 entities) | 18 | $384 |
| Pfizer | 7 | $236 |
| Incyte Corporation | 7 | $161 |
| LEO Pharma Inc. | 5 | $118 |
| Johnson & Johnson | 4 | $101 |
| Amgen | 2 | $57 |
| Galderma Laboratories, L.p. | 2 | $56 |
| Sanofi | 2 | $47 |
| Arcutis Biotherapeutics, Inc. | 2 | $45 |
| E.r. Squibb & Sons, L.L.C. | 2 | $45 |
| Dermavant Sciences, Inc. | 2 | $39 |
| UCB, Inc. | 1 | $29 |
| Organon | 1 | $28 |
| Genentech USA, Inc. | 1 | $25 |
| Boehringer Ingelheim | 1 | $22 |
| Sun Pharmaceutical Industries Inc. | 1 | $19 |
| Mimedx Group, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LIBTAYO$95,064
How this compares
$97,601 in reported general payments places this provider in the 95th percentile of 144 mohs-micrographic surgery providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Enbrel SureclickEtanercept | 14 | $110,741 |
| Fluorouracil | 28 | $1,586 |
| Calcipotriene | 16 | $1,537 |
| Clobetasol Propionate | 27 | $855 |
| Metronidazole | 16 | $758 |
| CiclopiroxCiclopirox Olamine | 16 | $708 |
| Triamcinolone Acetonide | 47 | $614 |
| ValacyclovirValacyclovir Hcl | 16 | $513 |
| Doxycycline Monohydrate | 30 | $474 |
| Betamethasone Dipropionate | 18 | $464 |
| Ketoconazole | 20 | $352 |
| Clindamycin Phosphate | 14 | $299 |
| Cefadroxil | 25 | $194 |
Paid to pharmacies, not to this prescriber.
Other mohs-micrographic surgery in Burlingame
- Daniel Zelacla Jolla$43K
- Ralph MasseySanta Monica$38K
- Michael MortazieOrange$29K
- Sumaira AasiStanford$27K
- Andrea WilleySacramento$21K
- Benjamin Kelleyla Jolla$20K
- Frank NoodlemanSaratoga$19K
- Howard FeinRolling Hills Estates$19K
- Joanna ChanLong Beach$18K
- Jared LundFresno$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.